ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

EPRXF Eupraxia Pharmaceuticals Inc (PK)

3.04
0.00 (0.00%)
Jun 13 2024 - Closed
Delayed by 15 minutes

Eupraxia Pharmaceuticals (PK) Financial Summary

The current EPRXF market cap is 82.88M. The company's latest EPS is USD -1.0351 and P/E is -3.53.

Year End December 30 2023 2020202120222023
CAD ($)CAD ($)CAD ($)USD ($)
Total Revenue 0000
Operating Income -2.25M-18.68M-23.2M-27.85M
Net Income -4.01M-22.99M-23.26M-28.22M
Year End December 30 2023 2020202120222023
CAD ($)CAD ($)CAD ($)USD ($)
Total Assets 1.45M31.22M25.88M20.27M
Total Liabilities 23.12M11.67M14.51M19.37M
Total Equity -21.66M19.55M11.36M892k

Cash Flow

Year End December 30 2023 2020202120222023
CAD ($)CAD ($)CAD ($)USD ($)
Operating -404k-14.64M-18.78M-20.68M
Investing 25k-14.45M8.7M-73k
Financing -627k49.92M13.52M21.01M
Market Cap 82.88M
Price to Earnings Ratio -3.53
Price to Sales Ratio 0
Price to Cash Ratio 5.14
Price to Book Ratio 111.56
Dividend Yield -

Share Statistics

Shares Outstanding 27.26M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -44.73%
52 Week High 6.7764
52 Week Low 2.9341
Spread (Intraday) 0 (0%)

Company Info

Company Name Eupraxia Pharmaceuticals Inc (PK)
Address 201 - 2067 cadboro bay road
victoria, british columbia V8R 5G4.
Website https://www.eupraxiapharma.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock